Immunotherapy with the trifunctional anti-CD20 × anti-CD3 antibody FBTA05 in a patient with relapsed t(8;14)-positive post-transplant lymphoproliferative disease.
about
Immunotherapy with the trifunctional anti-CD20 × anti-CD3 antibody FBTA05 in a patient with relapsed t(8;14)-positive post-transplant lymphoproliferative disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Immunotherapy with the trifunc ...... 5 in a patient with relapsed t
@nl
Immunotherapy with the trifunc ...... t lymphoproliferative disease.
@en
type
label
Immunotherapy with the trifunc ...... 5 in a patient with relapsed t
@nl
Immunotherapy with the trifunc ...... t lymphoproliferative disease.
@en
prefLabel
Immunotherapy with the trifunc ...... 5 in a patient with relapsed t
@nl
Immunotherapy with the trifunc ...... t lymphoproliferative disease.
@en
P2093
P2860
P1433
P1476
Immunotherapy with the trifunc ...... t lymphoproliferative disease.
@en
P2093
Angelika Eggert
Anna Kieslich
Horst Lindhofer
Patrick Hundsdoerfer
Raynold Buhmann
P2860
P304
P356
10.1080/10428194.2016.1272687
P577
2017-01-16T00:00:00Z